Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-29

Clinical Trial Update: Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes. [NA]

View source ↗

Summary

A completed clinical trial evaluating the effect of the beta-2 agonist formoterol on counterregulatory hormonal responses to hypoglycemia in individuals with Ty…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Formoterol (formoterol)

Snippet

Sponsor: Yale University | Conditions: Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2016-03-29